The prevalence of mental health symptoms prior to and following immunization with the coronavirus disease 2019 (COVID-19) vaccines was recently examined in a study of Swedish individuals.
Globally, the COVID-19 pandemic brought on by the SARS-CoV-2 coronavirus has had a significant detrimental effect on both infected and uninfected people’s mental health. Severely infected individuals have been found to have a higher chance of acquiring psychiatric illnesses, such as depression and anxiety, likely as a result of SARS-CoV-2-induced neuroinflammation.
In addition to direct infection, the pandemic’s social constraints and people’s fear of infection have led to a decline in the mental health of non-infected people.
COVID-
Worldwide, the number of cases and the severity of the disease have significantly decreased thanks to 19 vaccinations. Yet, little is known about how vaccinations affect mental health and wellness.
Researchers have identified the short-term alterations in mental health symptoms among people who have received the COVID-19 vaccinations in the current trial.
The study was conducted on 7,925 Swedish adults. Self-reported COVID-19 vaccination status was collected from the participants between July and October 2021. Self-reported depressive and anxiety symptoms were collected from the participants between December 2020 and October 2021.
The prevalence of mental health symptoms was estimated one month before and after the first vaccination and in some cases, one month after the second vaccination. The depressive and anxiety symptoms were estimated using the Patient Health Questionnaire and the Generalized Anxiety Disorder, respectively. The participants reporting no vaccination or chose not to report vaccination status were considered unvaccinated.
